Abiopharma

🔍 Evinger David M. (Director)

Company: CHAIN BRIDGE BANCORP INC (CBNA)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Sold 340 shares of Class B Common Stock (Derivative)
  Date: 2026-08-26 | Code: G | equity_swap_involved: 0 | shares_owned_after: 340.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Sold 340 shares of Class B Common Stock (Derivative)
  Date: 2026-08-26 | Code: G | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date.
• REMARKS: The reported securities were transferred as bona fide gifts to the reporting person's adult children. Following the transfers, the reporting person no longer holds any beneficial interest in the transferred securities. The shares transferred were held indirectly, co-owned with the reporting person's adult children. The zero beneficial ownership reflects only that co-owned indirect holding following the gifts and does not affect the reporting person's directly held shares.